Mark L. Berch

Array ( [id] => 6223034 [patent_doc_number] => 20100056538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'Pro-drugs of A2B Adenosine Receptor Antagonists' [patent_app_type] => utility [patent_app_number] => 12/618390 [patent_app_country] => US [patent_app_date] => 2009-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13161 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056538.pdf [firstpage_image] =>[orig_patent_app_number] => 12618390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6374708 [patent_doc_number] => 20100075945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'GRAM-POSITIVE CARBAPENEM ANTIBACTERIALS AND PROCESSES FOR THEIR PREPARATION' [patent_app_type] => utility [patent_app_number] => 12/613795 [patent_app_country] => US [patent_app_date] => 2009-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 43802 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 36 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20100075945.pdf [firstpage_image] =>[orig_patent_app_number] => 12613795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8363717 [patent_doc_number] => 08252781 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-28 [patent_title] => '1,2-diazetidin-3-one derivatives and drugs containing same' [patent_app_type] => utility [patent_app_number] => 12/607650 [patent_app_country] => US [patent_app_date] => 2009-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 69135 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12607650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6359895 [patent_doc_number] => 20100087455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'SUBSTITUTED XANTHINE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/574488 [patent_app_country] => US [patent_app_date] => 2009-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13245 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20100087455.pdf [firstpage_image] =>[orig_patent_app_number] => 12574488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7490518 [patent_doc_number] => 20110237607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'SUBSTITUTED PURINYL-PYRAZOL DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS' [patent_app_type] => utility [patent_app_number] => 13/120845 [patent_app_country] => US [patent_app_date] => 2009-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7002 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237607.pdf [firstpage_image] =>[orig_patent_app_number] => 13120845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487786 [patent_doc_number] => 20110251217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'SUBSTITUTED PURINYL-PYRAZOL DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS' [patent_app_type] => utility [patent_app_number] => 13/120833 [patent_app_country] => US [patent_app_date] => 2009-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6979 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20110251217.pdf [firstpage_image] =>[orig_patent_app_number] => 13120833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6495618 [patent_doc_number] => 20100010020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'PHOSPHODIESTERASE 4 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/564636 [patent_app_country] => US [patent_app_date] => 2009-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17103 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20100010020.pdf [firstpage_image] =>[orig_patent_app_number] => 12564636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8533400 [patent_doc_number] => 08309555 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-13 [patent_title] => 'Compositions and methods for inducing cell dedifferentiation' [patent_app_type] => utility [patent_app_number] => 12/563802 [patent_app_country] => US [patent_app_date] => 2009-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13338 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12563802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6603664 [patent_doc_number] => 20100063023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'Bicyclic and Tricyclic Substituted 6-Methylidene Carbapenems as Broad Spectrum Beta-Lactamase Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/555850 [patent_app_country] => US [patent_app_date] => 2009-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 72619 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20100063023.pdf [firstpage_image] =>[orig_patent_app_number] => 12555850 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5465782 [patent_doc_number] => 20090325982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'PHOSPHODIESTERASE 4 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/554301 [patent_app_country] => US [patent_app_date] => 2009-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19367 [patent_no_of_claims] => 91 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0325/20090325982.pdf [firstpage_image] =>[orig_patent_app_number] => 12554301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8701586 [patent_doc_number] => 08394808 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-12 [patent_title] => 'HM74 receptor agonists:xanthine derivatives, corresponding pharmaceutical compositions, treatment methods and processes' [patent_app_type] => utility [patent_app_number] => 12/552649 [patent_app_country] => US [patent_app_date] => 2009-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23795 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12552649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6374691 [patent_doc_number] => 20100075943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => '1-ADAMANTYLAZETIDIN-2-ONE DERIVATIVES AND DRUGS CONTAINING SAME' [patent_app_type] => utility [patent_app_number] => 12/550206 [patent_app_country] => US [patent_app_date] => 2009-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27133 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20100075943.pdf [firstpage_image] =>[orig_patent_app_number] => 12550206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6374631 [patent_doc_number] => 20100075935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'XANTHINE MODULATORS OF ADENOSINE A1 RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/545998 [patent_app_country] => US [patent_app_date] => 2009-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11940 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20100075935.pdf [firstpage_image] =>[orig_patent_app_number] => 12545998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6213971 [patent_doc_number] => 20110136777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'CRYSTALLINE SODIUM SALT OF CEPHALOSPORIN ANTIBIOTIC' [patent_app_type] => utility [patent_app_number] => 13/054262 [patent_app_country] => US [patent_app_date] => 2009-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3022 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20110136777.pdf [firstpage_image] =>[orig_patent_app_number] => 13054262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6498094 [patent_doc_number] => 20100010212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'Processes for the preparation of (3R,4S)-4-((4-benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-2-azetidinone, an intermediate for the synthesis of ezetimibe' [patent_app_type] => utility [patent_app_number] => 12/583305 [patent_app_country] => US [patent_app_date] => 2009-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10218 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20100010212.pdf [firstpage_image] =>[orig_patent_app_number] => 12583305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8363726 [patent_doc_number] => 08252791 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-28 [patent_title] => 'Purine compounds as cannabinoid receptor blockers' [patent_app_type] => utility [patent_app_number] => 12/540425 [patent_app_country] => US [patent_app_date] => 2009-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27604 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12540425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5374759 [patent_doc_number] => 20090312320 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'METHODS OF TREATMENT COMPRISING THE ADMINISTRATION OF HALOARYL SUBSTITUTED AMINOPURINES OR COMPOSITIONS THEREOF' [patent_app_type] => utility [patent_app_number] => 12/540013 [patent_app_country] => US [patent_app_date] => 2009-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34061 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312320.pdf [firstpage_image] =>[orig_patent_app_number] => 12540013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6257644 [patent_doc_number] => 20100029693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'NOVEL PI3K DELTA INHIBITORS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/538748 [patent_app_country] => US [patent_app_date] => 2009-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17778 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20100029693.pdf [firstpage_image] =>[orig_patent_app_number] => 12538748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7555525 [patent_doc_number] => 08067426 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-29 [patent_title] => '6-amino-purin-8-one compounds' [patent_app_type] => utility [patent_app_number] => 12/537392 [patent_app_country] => US [patent_app_date] => 2009-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 32001 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/067/08067426.pdf [firstpage_image] =>[orig_patent_app_number] => 12537392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7685376 [patent_doc_number] => 20100120765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'PYRAZOLYL SUBSTITUTED XANTHINES' [patent_app_type] => utility [patent_app_number] => 12/507472 [patent_app_country] => US [patent_app_date] => 2009-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9520 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120765.pdf [firstpage_image] =>[orig_patent_app_number] => 12507472 [rel_patent_id] =>[rel_patent_doc_number] =>)